Clinical Trials & Results
Search or filter the listing below to find a trial or results of a completed trial.
Showing 5 of 5 Results
All Results
No Results
No results found
Please change the filter settings to find the product(s) you are looking for. You can also use the search function to look up a product.
Efficacy and Safety of Reslizumab in Pediatric Patients With Eosinophilic Asthma
- Condition(s):
- Eosinophilic Asthma
- Status:
- Completed
- Requirements:
- 12 Years to 75 Years
- Interventions:
- Drug: Reslizumab | Drug: Placebo
Efficacy and Safety of Reslizumab Treatment in Patients With Moderate to Severe Asthma
- Condition(s):
- Eosinophilic Asthma
- Status:
- Completed
- Requirements:
- 18 Years to 65 Years
- Interventions:
- Drug: Reslizumab | Drug: Placebo
Evaluate the Efficacy and Safety of Reslizumab for Patients with Eosinophilic Asthma
- Condition(s):
- Eosinophilic Asthma
- Status:
- Completed
- Requirements:
- 12 Years to 75 Years
- Interventions:
- Drug: Reslizumab | Drug: Placebo
Evaluate the Safety and Efficacy of Reslizumab for Patients With Eosinophilic Asthma
- Condition(s):
- Eosinophilic Asthma
- Status:
- Terminated
- Requirements:
- 12 Years to 75 Years
- Interventions:
- Drug: Reslizumab
Study to Evaluate the Efficacy and Safety of Reslizumab in Patients With Eosinophilic Asthma
- Condition(s):
- Eosinophilic Asthma
- Status:
- Completed
- Requirements:
- 12 Years to 75 Years
- Interventions:
- Drug: Reslizumab | Drug: Placebo